Axiostat for Controlling Bleeding

Mechanism of Action and Clinical Effectiveness

Axiostat is an effective hemostatic agent recommended for controlling venous and moderate arterial bleeding, particularly in situations where access to the bleeding site is difficult, according to recent guidelines 1
Like other topical hemostatic agents, Axiostat serves as an adjunct to traditional surgical techniques to obtain hemorrhage control, as supported by the Critical Care journal 2, 3
Chitosan-based hemostatic agents like Axiostat are particularly useful when access to the site of bleeding is challenging, highlighting their value in complex cases 1

Axiostat is recommended for venous or moderate arterial bleeding associated with parenchymal injuries, providing a clear indication for its use 1
The use of topical hemostatic agents, including Axiostat, should consider factors such as type of surgical procedure, cost, severity of bleeding, and coagulation status, emphasizing the need for a comprehensive approach 2, 4
European guidelines recommend using topical hemostatic agents, such as Axiostat, in combination with other surgical measures or with packing for optimal results, underscoring the importance of a multifaceted strategy 1, 2

Gelatine-based products work by swelling in contact with blood to reduce blood flow, offering an alternative mechanism of action compared to Axiostat 2, 5
Fibrin and synthetic glues have both hemostatic and sealant properties, providing a distinct set of benefits in certain clinical scenarios 2, 7